Cronos Group (CRON)
Branded cannabis portfolio across Canada, Israel, and other international markets.
$3.41
vs last close−0.02 (−0.73%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25 | 24 | 25 | 28 | 34 | 30 | 32 | 33 | 36 | 91 | 45 | 71 |
| Cost of revenue | 21 | 22 | 21 | 21 | 31 | 19 | 19 | 19 | 18 | 75 | 26 | 42 |
| Gross profit | 4 | 2 | 4 | 6 | 4 | 11 | 14 | 15 | 18 | 16 | 18 | 28 |
| 26 | 24 | 20 | 22 | 37 | 22 | 18 | 20 | 19 | 9 | 20 | 21 | |
| Research & development | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 22 | 18 | 16 | 19 | 21 | 21 | 16 | 17 | 17 | 14 | 17 | 18 | |
| Selling & marketing | 5 | 6 | 5 | 4 | 6 | 6 | 5 | 5 | 5 | 7 | 6 | 7 |
| General & administrative | 16 | 12 | 11 | 15 | 15 | 14 | 11 | 12 | 12 | 7 | 12 | 11 |
| Other expenses | 3 | 4 | 3 | 2 | 15 | 0 | 1 | 2 | 1 | −6 | 1 | 2 |
| Operating income | −22 | −22 | −16 | −16 | −34 | −11 | −4 | −5 | −1 | 7 | −1 | 7 |
| 19 | −24 | 13 | 5 | 38 | 57 | 11 | −34 | 28 | −19 | 19 | 28 | |
| Interest income | 13 | 14 | 14 | 13 | 12 | 12 | 10 | 9 | 12 | 10 | 9 | 9 |
| Other non-operating income | −1 | −3 | −2 | −1 | −14 | 2 | −1 | −1 | −28 | 43 | 0 | −28 |
| Income before tax | −3 | −46 | −3 | −11 | 5 | 46 | 7 | −39 | 27 | −12 | 18 | 36 |
| Income tax expense | −1 | 0 | −1 | −2 | −3 | 2 | 0 | −1 | −1 | −12 | 2 | 0 |
| Net income from continuing operations | −2 | −45 | −2 | −9 | 7 | 44 | 8 | −38 | 28 | 0 | 15 | 36 |
| Discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −2 | −45 | −2 | −9 | 8 | 44 | 6 | −40 | 26 | −2 | 14 | 32 |
| EPS, basic | −$0.00 | −$0.12 | −$0.01 | −$0.02 | $0.02 | $0.12 | $0.02 | −$0.10 | $0.07 | −$0.00 | $0.04 | $0.08 |
| EPS, diluted | −$0.00 | −$0.12 | −$0.01 | −$0.02 | $0.02 | $0.11 | $0.02 | −$0.10 | $0.07 | −$0.00 | $0.04 | $0.08 |
| Weighted average shares, basic | 381 | 381 | 381 | 382 | 382 | 382 | 383 | 385 | 385 | 385 | 385 | 385 |
| Weighted average shares, diluted | 381 | 381 | 381 | 382 | 386 | 387 | 387 | 385 | 385 | 385 | 385 | 385 |
| EBITDA | −18 | −17 | −12 | −14 | −16 | −11 | −1 | 0 | 31 | −45 | 2 | 36 |
| Depreciation & amortization | 2 | 1 | 2 | 2 | 4 | 2 | 3 | 4 | 4 | −8 | 4 | 0 |
| EBIT | −20 | −18 | −14 | −15 | −19 | −13 | −4 | −5 | 27 | −36 | −1 | 36 |